Stock Research for GERN

GERN

Featured Broker: Ally Invest

Get the due diligence for another stock.

 

GERN Stock Chart & Research Data

The GERN chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the GERN chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


GERN Due diligence Resources & Stock Charts

The GERN stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View GERN Detailed Price Forecast - CNN Money CNN View GERN Detailed Summary - Google Finance
Yahoo View GERN Detailed Summary - Yahoo! Finance Zacks View GERN Stock Research & Analysis - Zacks.com

Stock Analysis

TradeIdeas View GERN Trends & Analysis - Trade-Ideas Barrons View GERN Major Holders - Barrons
NASDAQ View GERN Call Transcripts - NASDAQ Seeking View GERN Breaking News & Analysis - Seeking Alpha
Spotlight View GERN Annual Report - CompanySpotlight.com OTC Report View GERN OTC Short Report - OTCShortReport.com
TradeKing View GERN Fundamentals - TradeKing Charts View GERN SEC Filings - Bar Chart
WSJ View Historical Prices for GERN - The WSJ Morningstar View Performance/Total Return for GERN - Morningstar
MarketWatch View the Analyst Estimates for GERN - MarketWatch CNBC View the Earnings History for GERN - CNBC
StockMarketWatch View the GERN Earnings - StockMarketWatch MacroAxis View GERN Buy or Sell Recommendations - MacroAxis
Bullish View the GERN Bullish Patterns - American Bulls Short Pains View GERN Short Pain Metrics - ShortPainBot.com

Social Media Mentions

StockTwits View GERN Stock Mentions - StockTwits PennyStocks View GERN Stock Mentions - PennyStockTweets
Twitter View GERN Stock Mentions - Twitter Invest Hub View GERN Investment Forum News - Investor Hub
Yahoo View GERN Stock Mentions - Yahoo! Message Board Seeking Alpha View GERN Stock Mentions - Seeking Alpha


Financial & Transaction Holdings

SECform4 View Insider Transactions for GERN - SECform4.com Insider Cow View Insider Transactions for GERN - Insider Cow
CNBC View GERN Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for GERN - OTC Markets
Yahoo View Insider Transactions for GERN - Yahoo! Finance NASDAQ View Institutional Holdings for GERN - NASDAQ


Stock Charts

FinViz View GERN Stock Insight & Charts - FinViz.com StockCharts View GERN Investment Charts - StockCharts.com
BarChart View GERN Stock Overview & Charts - BarChart Trading View View GERN User Generated Charts - Trading View




Latest Financial News for GERN


Geron Appoints Vice President, Pharmacovigilance and Drug Safety
Posted on Thursday January 17, 2019

Geron Corporation (GERN) today announced the hiring of the first of several key leadership positions as it rebuilds the in-house development team to support its plans to initiate a Phase 3 clinical trial of imetelstat in lower risk myelodysplastic syndromes by mid-year 2019. Israel Gutierrez, M.D., has joined the Company as Vice President, Pharmacovigilance and Drug Safety, as of January 16, 2019. Dr. Gutierrez will lead and direct the oversight of clinical drug safety risk management and compliance at Geron and will be responsible for product safety-related recommendations and decisions.


Why Geron Stock Dropped 44% in 2018
Posted on Tuesday January 15, 2019

Johnson & Johnson's decision to hand back imetelstat's rights caused Geron's share price to crumble last year.


Geron Announces New Board Leadership Structure
Posted on Monday December 31, 2018

For personal reasons, effective December 26, 2018, Hoyoung Huh, M.D., Ph.D., has resigned from the Board, including his roles as Chairman of the Board and as a member of the Nominating and Corporate Governance Committee. Dr. Huh has served as Chairman of the Board since September 2011, and as a member of the Board since May 2010.


Biotech Breakout Candidates
Posted on Monday December 24, 2018

HENDERSON, NV / ACCESSWIRE / December 24, 2018 / It’s been a busy week for biotech, here are a few companies in the news you should start researching. Today we are highlighting: Delcath Systems, Inc. (DCTH), ...


Stock Market & Investing Books

Enter a stock symbol to view the stock details.